2007;4(8):432-443. Raman and colleagues reported that, following definitive surgical resection of upper-tract TCC (nephroureterectomy or segmental ureterectomy), bladder tumors developed in 44% of ...

High-risk, non-muscle-invasive bladder cancer is defined as any transitional cell carcinoma (TCC) of the bladder that is high-grade, whether it is primary or recurrent. This high-risk group ...

Carcinoma of the urinary bladder is a common malignancy and a major cause of morbidity and mortality in the western world. Current understanding of etiology, disease process, molecular ...

Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection In metastatic transitional cell carcinoma of the bladder?J Urol 2003; 169: 2113–7. MEDLINE 21. Siefker ...

This trial is for people with non muscle invasive bladder cancer who are going to have treatment with BCG into the bladder for the first time. Read more about A trial looking at durvalumab and BCG for ...

Instead, transitional cell carcinoma starts in your renal pelvis, the top part of your ureter. Your ureter is the tube that ...

Sasanlimab (PF-06801591) added to BCG therapy significantly improved outcomes for patients with BCG-naive, high-risk ...

This trial looked at different doses of radiotherapy for transitional cell bladder cancer. It was for people whose cancer had grown into the wall of the bladder. This is called muscle invasive bladder ...

A new method has been found for detecting upper urinary tract transitional cell carcinoma by a team of ... products and one that tested for bladder tumor antigen BTA. The samples were also ...